Viewing Study NCT03025256


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-02-20 @ 8:15 PM
Study NCT ID: NCT03025256
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-03
First Post: 2017-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2016-0567
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View